- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- May 28, 2021
Highlights
- Market Cap
- $388.45
- Enterprise Value
- $1.01M
- EPS (TTM)
- -$2.58
- Total Revenue (TTM)
- $119.03K
- Gross Profit (TTM)
- $39.21K
- EBITDA (TTM)
- -$9.86M
- Year Range
- $0.00 - $1.00
- ROA (TTM)
- -1,490.71%
- ROE (TTM)
- 263.93%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ZIVOW Performance Chart
Zivo Bioscience Inc. Warrants (ZIVOW) is down 99.9% since the beginning of the year. At $0 per share, ZIVOW is trading 100.0% below its 52-week high of $1. Investors who bought $1,000 worth of ZIVOW shares 5 years ago would now be looking at an investment worth $0.
Loading charts...
Returns By Period
Zivo Bioscience Inc. Warrants (ZIVOW) has returned -99.92% so far this year and -99.98% over the past 12 months.
Zivo Bioscience Inc. Warrants
- 1D
- 0.00%
- 1M
- -98.00%
- YTD
- -99.92%
- 6M
- -99.96%
- 1Y
- -99.98%
- 3Y*
- -94.41%
- 5Y*
- -84.15%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
ZIVOW Monthly Returns History
Based on dividend-adjusted daily data since May 28, 2021, ZIVOW's average daily return is +2.58%, while the average monthly return is +21.54%. At this rate, an investment would double in approximately 0.3 years.
Historically, 36% of months were positive and 64% were negative. The best month was Jan 2024 with a return of +1,500.0%, while the worst month was Jun 2026 at -97.8%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 7 months.
On a daily basis, ZIVOW closed higher 24% of trading days. The best single day was May 5, 2026 with a return of +978.0%, while the worst single day was Jun 1, 2026 at -97.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -61.13% | -1.96% | -19.28% | -87.61% | -10.60% | -97.76% | -99.92% | ||||||
| 2025 | -8.65% | -15.66% | -46.43% | 34.67% | -49.50% | -0.00% | -62.75% | 123.89% | 123.30% | -78.92% | 24.88% | -47.52% | -92.78% |
| 2024 | 1,500.00% | -25.78% | -15.79% | -32.50% | -16.67% | -11.11% | 140.00% | 54.17% | -34.46% | 31.96% | 103.13% | 39.77% | 4,442.50% |
| 2023 | 10.35% | -16.47% | -17.94% | 8.14% | -4.78% | 0.00% | -12.49% | -4.91% | -10.26% | -45.40% | -83.65% | 0.00% | -94.81% |
| 2022 | -24.44% | -1.44% | -8.10% | 8.80% | 24.45% | -15.16% | -5.28% | 21.44% | -29.11% | 33.74% | -13.14% | 10.04% | -18.05% |
| 2021 | 76.46% | -28.66% | -16.87% | 12.42% | 1.00% | -10.91% | 4.46% | 10.58% |
Benchmark Metrics
Zivo Bioscience Inc. Warrants has an annualized alpha of 50828.19%, beta of 1.39, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since June 01, 2021.
- This stock participated in 169.52% of S&P 500 Index downside but only -161.76% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 50,828.19%
- Beta
- 1.39
- R²
- 0.00
- Upside Capture
- -161.76%
- Downside Capture
- 169.52%
Return for Risk
Risk / Return Rank
ZIVOW ranks 49 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Zivo Bioscience Inc. Warrants (ZIVOW) and compare them to S&P 500 Index.
| ZIVOW | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.33 | ||
| Sortino ratioReturn per unit of downside risk | +3.77 | ||
| Omega ratioGain probability vs. loss probability | 2.67 | 1.41 | +1.26 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | 2.93 | -3.93 |
| Martin ratioReturn relative to average drawdown | -1.36 | 13.52 | -14.89 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Zivo Bioscience Inc. Warrants. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Zivo Bioscience Inc. Warrants was 100.00%, occurring on Jun 1, 2026. The portfolio has not yet recovered.
The current Zivo Bioscience Inc. Warrants drawdown is 100.00%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -100.00%Jun 2026 | 1y 4mo | — | 1y 4moJan 2025 - now |
2023 bear market2023 | -97.70%Nov 2023 | 2y 4mo | 1y 28d | 3y 5moJul 2021 - Dec 2024 |
2024 bear market2024 | -37.00%Dec 2024 | 0s | 8d | 8dDec 2024 - Jan 2025 |
2021 correction2021 | -14.97%Jun 2021 | 0s | 18d | 18dJun 2021 - Jun 2021 |
2021 correction2021 | -12.28%Jun 2021 | 0s | 4d | 4dJun 2021 - Jun 2021 |
Drawdown Indicators
| ZIVOW | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -56.78% | -43.22% |
Max Drawdown (1Y)Largest decline over 1 year | -99.99% | -9.10% | -90.89% |
Max Drawdown (3Y)Largest decline over 3 years | -100.00% | -18.90% | -81.10% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -25.43% | -74.57% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -100.00% | -0.74% | -99.26% |
Average DrawdownAverage peak-to-trough decline | -63.61% | -10.72% | -52.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 73.89% | 1.97% | +71.92% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Zivo Bioscience Inc. Warrants over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Zivo Bioscience Inc. Warrants is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ZIVOW relative to other companies in the Biotechnology industry. Currently, ZIVOW has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ZIVOW
Add Zivo Bioscience Inc. Warrants to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ZIVOW